• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Hum Vaccin Immunother . Determinants of seasonal influenza and COVID-19 vaccine uptake in high-risk individuals in northern Sweden

tetano

Editor, Senior Moderator
Hum Vaccin Immunother


. 2026 Dec;22(1):2688595.
doi: 10.1080/21645515.2026.2688595. Epub 2026 Jul 28.
Determinants of seasonal influenza and COVID-19 vaccine uptake in high-risk individuals in northern Sweden

Lucas Grape[SUP] 1 [/SUP], Wilma Persson[SUP] 1 [/SUP], Adam Sergejev[SUP] 1 [/SUP], Simon Vihtari Hansson[SUP] 1 [/SUP], Lina Gyllencreutz[SUP] 2 [/SUP], Henrik Togstad[SUP] 3 [/SUP], Johan Normark[SUP] 1 [/SUP], Urban Johansson Kostenniemi[SUP] 1 [/SUP]


Affiliations
Abstract

Seasonal influenza and COVID-19 vaccination in high-risk individuals prevent disease, disability, and death. Nevertheless, many high-income countries continue to experience suboptimal vaccine coverage. We therefore aimed to identify the remaining vaccination barriers in these settings. We recruited patients seeking emergency department care at a hospital in northern Sweden. Using semi-structured interviews and medical records, we collected high-resolution individual-level data, and linked community-level determinants from national registers. Logistic regression was used to calculate odds ratios (OR) and adjusted odds ratios (aOR) for determinants associated with influenza and COVID-19 vaccination. We included 600 patients of whom 450 were eligible for both vaccines. Coverage among eligible individuals was 52.0% for influenza and 54.2% for COVID-19. Co-administration of both vaccines was high (OR 55.33, 95% CI: 30.86-99.22). Individual-level determinants associated with lower vaccine uptake included male biological sex (aOR: 0.57, 95% CI: 0.37-0.88, younger age (aOR: 0.50, 95% CI: 0.41-0.61), smoking (aOR: 0.43, 95% CI: 0.18-1.02), reduced independence (aOR: 0.59, 95% CI: 0.31-1.10), and age-only eligibility (aOR 0.41, 95% CI: 0.19-0.86). In multimorbid individuals, meeting more eligibility criteria showed no significant association with higher uptake (aOR: 1.14, 95% CI: 0.93-1.39). Finally, we noted only limited influence of community-level determinants. In conclusion, vaccine uptake for influenza and COVID-19 was primarily associated with individual-level determinants, whereas community-level showed little impact. Targeted communication, such as risk-stacking to improve risk-awareness, harmonized eligibility criteria, and co-administration, may help overcome remaining vaccination barriers in high-risk individuals.

Keywords: COVID-19 vaccines; Vaccination; health knowledge, attitudes, practice; influenza vaccines; patient acceptance of health care; risk factors.

 
Back
Top